Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis.

Lin, Hung-Jen; Ku, Ko-Li; Lin, I-Hsin; Yeh, Chia-Chou

Lin, Hung-Jen; Ku, Ko-Li; Lin, I-Hsin; Yeh, Chia-Chou.

Affiliation

Lin HJ; School of Post-baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan.
Ku KL; Division of Chinese Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Lin IH; Department of Chinese Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, 62247, Taiwan.
Yeh CC; School of Post-baccalaureate Chinese Medicine, Tzu Chi University, Hualien, Taiwan.

BMC Complement Altern Med ; 17(1): 505, 2017 Nov 28.

Article in En | MEDLINE | ID: mdl-29183361

Subject(s)

Fatty Liver/metabolism; Flavanones/pharmacology; Liver/drug effects; Trans-Activators/metabolism; Animals; Fatty Liver/pathology; Hep G2 Cells; Humans; Liver/metabolism; Liver/pathology; Male; Mice; Mice, Transgenic; Sterol Regulatory Element Binding Protein 1/metabolism; Trans-Activators/genetics; Viral Regulatory and Accessory Proteins

Key words

Adiponectin; CD36; FAS; HBx; Hepatic steatosis; LXRα; Naringenin; PPARÎ³; SREBP1c; aP2

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Trans-Activators / Flavanones / Fatty Liver / Liver Limits: Animals / Humans / Male Language: En Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Trans-Activators / Flavanones / Fatty Liver / Liver Limits: Animals / Humans / Male Language: En Year: 2017 Type: Article